6 drug shortages to watch

Six drugs have been listed as in shortage since the beginning of September, according to data from the FDA and the American Society of Health-System Pharmacists. 

Editor's note: The drugs are listed in alphabetical order.

1. Betamethasone acetate and betamethasone sodium phosphate suspension: This injectable corticosteroid is available in certain dosages in limited quantities. Two main producers reporting shortages are American Regent and Organon, neither of which provided a reason for the shortage. 

2. Cisatracurium besylate injections: AbbVie discontinued three solutions of the muscle relaxers used before and during surgery. 

3. Copper chloride injections: Pfizer is facing a shortage of this drug, typically used as an additive to intravenous solutions, which it attributes to manufacturing delays. The company has a limited supply of vials available for direct order only in the case of emergency.

4. Hydroxocobalamin intramuscular solutions: Teva reported a shortage of multiple dosages of this drug, typically used to treat vitamin B12 deficiencies. It has vials on back order and estimates a restock in mid-November. 

5. Levofloxacin oral solutions: Lanet has reported a shortage of multiple dosages of this medication used to treat bacterial infections. Oral tablets are still available, but the manufacturer is unable to estimate a restock date. 

6. Vinblastine sulfate injections: This cancer medication's 10 milliliter vials are back ordered, according to Fresenius Kabi, the manufacturer. It estimates a resupply in late September.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like

Thank you so much for your interest in our content. Please register to access this complimentary archived content.

 

 

Already Registered? Click here to confirm.